APA (7th ed.) Citation

TK, R., LY, L., SR, P., TA, S., M, P., GW, B., . . . RG, C. (1999). Angiogenesis gene therapy: Phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease. Circulation, 100(5), 468. https://doi.org/10.1161/01.cir.100.5.468

Chicago Style (17th ed.) Citation

TK, Rosengart, et al. "Angiogenesis Gene Therapy: Phase I Assessment of Direct Intramyocardial Administration of an Adenovirus Vector Expressing VEGF121 CDNA to Individuals with Clinically Significant Severe Coronary Artery Disease." Circulation 100, no. 5 (1999): 468. https://doi.org/10.1161/01.cir.100.5.468.

MLA (9th ed.) Citation

TK, Rosengart, et al. "Angiogenesis Gene Therapy: Phase I Assessment of Direct Intramyocardial Administration of an Adenovirus Vector Expressing VEGF121 CDNA to Individuals with Clinically Significant Severe Coronary Artery Disease." Circulation, vol. 100, no. 5, 1999, p. 468, https://doi.org/10.1161/01.cir.100.5.468.